News

Sigachi Industries Limited held its 1st Extraordinary General Meeting on Tuesday, September 15, 2026, via video conference, where shareholders approved an increase in the company’s authorized share capital and the issue of up to 11,00,00,000 convertible warrants to promoters and non-promoters on a preferential basis. The meeting, attended by 58 members, was chaired by Mr. Amit Raj Sinha, and M/s. Aakanksha Dubey & Co. was appointed as the scrutinizer for the e-voting process.

Sigachi Industries Limited issued a corrigendum to the notice of its Extraordinary General Meeting (EGM) scheduled for September 15, 2026, following suggestions from the BSE Limited and National Stock Exchange of India Limited. The company seeks in-principle approval for the issuance of 11,00,00,000 convertible warrants at a price of Rs 26.40 each, intending to utilize Rs 290.40 crore for expanding Microcrystalline Cellulose (MCC) production in Dahej, Gujarat, establishing a Croscarmellose Sodium (CCS) facility in Dahej, expanding Active Pharmaceutical Ingredients (API) manufacturing in Raichur, and for working capital and general corporate purposes. The company has appointed Care Ratings Limited as the monitoring agency for the utilization of the preferential issue proceeds.

Sigachi Industries Limited will hold a board meeting on Saturday, August 22, 2026, to consider a proposal to raise funds through the issue of equity shares, convertible warrants, or convertible securities via a preferential issue to promoters, promoter group, and non-promoters, subject to regulatory approvals, according to a filing with the Bombay Stock Exchange and National Stock Exchange. Trading in the company`s securities will be closed from August 19, 2026, until 48 hours after the board meeting`s conclusion for designated persons, their immediate relatives, and connected persons.

Sigachi Industries Ltd share price ticked higher by 1.59% to Rs 26.18 after the company`s net profit saw a mild growth of 6.41% to Rs 8.14 crore, while revenue from operations softened by 0.52% to Rs 121.27 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, rising 4.59%. It has improved by 0.97% over last one week and climbed by 11.17% in last one month while the market capitalization of Sigachi Industries Ltd has marginally improved by 1.35% and 27.58% in the same period respectively. Profit before tax (PBT) of Sigachi Industries Ltd stood at Rs 10.09 crore in Q2 FY26, nosediving by 109.99% year-on-year, and rallying 30.87% quarter-on-quarter. EBITDA came in at Rs 16 crore, tumbling by 23.07% YoY and gaining 2.99% sequentially. Total expenses marginally dropped 0.81% to Rs 109.17 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 54.73 crore, jumping 31.28% YoY, while employee benefits expense was at Rs 28.45 crore, seeing a marginal contraction of 1.22% YoY. For the TTM ended FY26, revenue from operations soared by 22.38% to Rs 488.24 crore, while net profit surged by 23.03% to Rs 70.46 crore, compared to previous TTM. EBITDA jumped by 6894% to Rs 79.47 crore, and PBT witnessed a strong rise of 32.32% to Rs 92.32 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 26.93 crore in FY26, as against Rs 12.89 crore in FY25. Sigachi Industries Ltd plunged by 16.57% in last one year, underperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.

Sigachi Industries will hold a meeting of the Board of Directors of the Company on 13 August 2026.